Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Virag Dandekar"'
Autor:
Jennifer Young, David J. Sher, Mary J. Fidler, Marta Batus, Philip Bonomi, K Kiel, Virag Dandekar
Publikováno v:
American Journal of Clinical Oncology. 38:605-609
Introduction To assess the efficacy and tolerability of palliative split-course concurrent thoracic chemoradiotherapy (CRT) in patients with incurable locally advanced and metastatic non-small cell lung cancer. Methods All patients with incurable non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad9aaf38ca1cb0966862ea39bb406ee6
https://doi.org/10.1097/coc.0000000000000007
https://doi.org/10.1097/coc.0000000000000007
Autor:
Everett E. Vokes, Daniel J. Haraf, Mary Ellyn Witt, Loren K. Mell, Ralph R. Weichselbaum, Blase N. Polite, Ezra E.W. Cohen, James J. Dignam, Amit D. Bhate, Joseph K. Salama, Virag Dandekar, Bharat B. Mittal
Publikováno v:
Journal of Clinical Oncology. 28:15-20
Purpose Death from noncancer causes (competing mortality) is an important event in head and neck cancer, but studies identifying predictors of this event are lacking. We sought to identify predictors of competing mortality and develop a risk stratifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf4d6125eff21402ff853f58f1d8643
https://doi.org/10.1200/jco.2008.20.9288
https://doi.org/10.1200/jco.2008.20.9288
Publikováno v:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 41(1)
Small bowel (SB) is an organ at risk (OAR) that may potentially develop toxicity after radiotherapy for cervix cancer. However, its dose from brachytherapy (BT) is not systematically reported as in other OARs, even with image-guided brachytherapy (IG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c036afa7ea216d557267c25231ea6c61
https://pubmed.ncbi.nlm.nih.gov/26235549
https://pubmed.ncbi.nlm.nih.gov/26235549
Autor:
Mary J. Fidler, Tiffany Morgan, Julius V. Turian, Aidnag Z. Diaz, Virag Dandekar, Thomas E. Nielsen, J.L. Showel, David J. Sher, Joy L. Coleman
Publikováno v:
Oral oncology. 50(5)
Summary Objectives There is debate about the optimal clinical target volume (CTV) expansion and prophylactic nodal dose (PND) in head and neck IMRT. We evaluated our patterns-of-failure (POF) after helical tomotherapy-based concurrent chemoradiothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::878bb7abeafb61baa5386896179f49f0
https://pubmed.ncbi.nlm.nih.gov/24613544
https://pubmed.ncbi.nlm.nih.gov/24613544
Publikováno v:
Current problems in cancer. 37(4)
Current curative intent treatment paradigms for young patients with primary bone tumors have evolved from single modality surgery to include multimodality approaches with surgery and chemotherapy, reserving radiotherapy (RT) for unresectable or margi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7baeba725f33452a7caa0022d6a06fb5
https://pubmed.ncbi.nlm.nih.gov/24238585
https://pubmed.ncbi.nlm.nih.gov/24238585
Autor:
M. Yeginer, Loren K. Mell, Catheryn M. Yashar, Y. Liang, Arno J. Mundt, Bulent Aydogan, Michael D. Hasselle, Rounak Bafana, Brent S. Rose, Virag Dandekar, John C. Roeske
Publikováno v:
International journal of radiation oncology, biology, physics. 79(3)
Purpose To test the hypothesis that increased pelvic bone marrow (BM) irradiation is associated with increased hematologic toxicity (HT) in cervical cancer patients undergoing chemoradiotherapy and to develop a normal tissue complication probability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ab0b7e58a6b5f65946989f4f215a7d
https://pubmed.ncbi.nlm.nih.gov/20400238
https://pubmed.ncbi.nlm.nih.gov/20400238
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 87:S725
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a30882829de2311d7ab1aabb53c0c69
https://doi.org/10.1016/j.ijrobp.2013.06.1921
https://doi.org/10.1016/j.ijrobp.2013.06.1921
Publikováno v:
Medical Physics. 40:369-369
Purpose: Small bowel (SB) is the organ at risk (OAR) that has the highest rate of radiation induced late toxicity in brachytherapy of cervical cancer. Historically, however, its dose has not been systematically reported as other OARs even during imag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d480c2bee8cdf88890c48f951539570
https://doi.org/10.1118/1.4815135
https://doi.org/10.1118/1.4815135
Publikováno v:
Medical Physics. 39:3803-3803
Purpose:Brachytherapy is a vital part of treating locally advanced cervix cancer. Point‐based 2D treatment planning is conventionally used. New CT/MRI‐compatible applicators for HDR brachytherapy make 3D conformal planning possible. GEC‐ESTRO e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7254857644c02ee3d4371e6b4296b5b7
https://doi.org/10.1118/1.4735519
https://doi.org/10.1118/1.4735519